- Home
- EXTR vs KYMR Comparison
EXTR vs KYMR Comparison
Compare EXTR & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXTR
- KYMR
- Stock Information
- Founded
- EXTR 1996
- KYMR 2015
- Country
- EXTR United States
- KYMR United States
- Employees
- EXTR N/A
- KYMR N/A
- Industry
- EXTR Telecommunications Equipment
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- EXTR Telecommunications
- KYMR Health Care
- Exchange
- EXTR Nasdaq
- KYMR Nasdaq
- Market Cap
- EXTR 2.6B
- KYMR 3.1B
- IPO Year
- EXTR 1999
- KYMR 2020
- Fundamental
- Price
- EXTR $22.68
- KYMR $51.16
- Analyst Decision
- EXTR Strong Buy
- KYMR Strong Buy
- Analyst Count
- EXTR 6
- KYMR 17
- Target Price
- EXTR $21.42
- KYMR $60.18
- AVG Volume (30 Days)
- EXTR 1.3M
- KYMR 679.6K
- Earning Date
- EXTR 10-29-2025
- KYMR 10-30-2025
- Dividend Yield
- EXTR N/A
- KYMR N/A
- EPS Growth
- EXTR N/A
- KYMR N/A
- EPS
- EXTR N/A
- KYMR N/A
- Revenue
- EXTR $1,140,067,000.00
- KYMR $44,711,000.00
- Revenue This Year
- EXTR $10.26
- KYMR $63.75
- Revenue Next Year
- EXTR $7.48
- KYMR N/A
- P/E Ratio
- EXTR N/A
- KYMR N/A
- Revenue Growth
- EXTR 2.05
- KYMR N/A
- 52 Week Low
- EXTR $10.10
- KYMR $19.45
- 52 Week High
- EXTR $22.89
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- EXTR 64.69
- KYMR 71.70
- Support Level
- EXTR $22.05
- KYMR $47.86
- Resistance Level
- EXTR $22.70
- KYMR $44.43
- Average True Range (ATR)
- EXTR 0.60
- KYMR 2.01
- MACD
- EXTR -0.05
- KYMR 0.84
- Stochastic Oscillator
- EXTR 90.87
- KYMR 94.65
About EXTR Extreme Networks Inc.
Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.